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 Abstract 
The yeast Saccharomyces cerevisiae was chosen as a microbial host for heterologous 
biosynthesis of three different plant sesquiterpenes, namely valencene, cubebol and patchoulol. 
The volatility and low solubility of the sesquiterpenes were major practical problems for 
quantification of the excreted sesquiterpenes. In situ separation of sesquiterpenes in a two phase 
fermentation using dodecane as the secondary phase was therefore performed in order to enable 
quantitative evaluation of different strains. In order to enhance the availability of the precursor 
for synthesis of sesquiterpenes, farnesyl diphosphate (FPP), the ERG9 gene which is responsible 
for conversion of FPP to squalene was downregulated by replacing the native ERG9 promoter 
with the regulatable MET3 promoter combined with addition of 2 mM methionine to the medium. 
This strategy led to a reduced ergosterol content of the cells and accumulation of FPP derived 
compounds like target sesquiterpenes and farnesol. Adjustment of the methionine level during 
fermentations prevented relieving MET3 promoter repression and resulted in further improved 
sesquiterpene production. Thus, the final titer of patchoulol and farnesol in the ERG9 
downregulated strain reached 16.9 and 20.2 mg/L, respectively. The results obtained in this study 
revealed the great potential of yeast as a cell factory for production of sesquiterpenes.  
 
INTRODUCTION 
Isoprenoids with more than 40,000 described compounds (Withers and Keasling, 2007) are the 
largest and most structurally diverse group of plant metabolites. Isoprenoids play many different 
biological roles in plants. Some of them play essential functional roles in photosynthesis 
(chlorophylls, plastoquinone, and carotenoids), photoprotection (carotenoids), growth regulation 
(gibberellic acid, abscisic acid, cytokinins, and brassinosteroids) and membrane structure and 
 function (phytosterols) (Chappell, 1995; McGarvey and Croteau, 1995; Wanke et al., 2001). 
However, most of the plant isoprenoids are not essential for viability and cell growth and are 
considered as secondary metabolites.  
Isopentenyl diphosphate (IPP) which is the universal biological precursor of all isoprenoids 
(basic C5 isoprene unit) can be obtained either through the mevalonate (MVA) or the 2-
methylerythritol 4-phosphate (MEP) pathways.  
Depending on the number of isoprene units, isoprenoids can be classified into several groups, 
such as monoterpenes, sesquiterpenes and diterpenes (respectively 2, 3 and 4 C5 units).  
Sesquiterpenes are the most diverse class of isoprenoids with more than 300 identified carbon 
skeletons (Cane, 1999) and more than 7,000 characterized compounds (Connolly and Hill, 1991). 
From an industrial point of view, sesquiterpenes are interesting compounds because of their 
potent anticancer, antitumor, cytotoxic, antiviral and antibiotic properties as well as their 
characteristic flavours and aromas. Most sesquiterpenes are constituents of plant essential oils, 
but extraction from plants is not a suitable method for large scale production of many 
sesquiterpenes. Furthermore, using plants as resources for industrial production of sesquiterpenes 
include slow growth, varying composition and concentration depending on the geographical 
position and climate conditions. There is therefore much interest in using microorganisms as cell 
factories for the production of isoprenoids. The intracellular pools of isoprenoid precursors in 
microorganisms appear, to be however, not enough to provide high level production. It may 
therefore be necessary to deregulate the pathways involved in the biosynthesis of isoprenoid 
precursors in order to improve production (Kim and Keasling, 2001, Martin et al., 2003; Pitera et 
al., 2007). In the last decade numerous studies have been conducted with regard to engineer 
microorganisms for the production of different isoprenoids (For review see Maury et al., 2005).  
 In most studies Escherichia coli has been used as the host of interest for metabolic engineering of 
isoprenoid production (Alper et al., 2005; Carter et al., 2003; Martin et al., 2001). However, in 
some cases the MVA pathway in yeasts has been deregulated to improve the biosynthesis of 
different isoprenoids (DeJong et al., 2006; Jackson et al., 2003; Miura et al., 1998a; Miura et al., 
1998b; Ro et al., 2006; Shimada et al., 1998; Yamano et al., 1994). In Saccharomyces cerevisiae 
the MVA pathway is the only pathway involved in the biosynthesis of isoprenoid precursors. 
This pathway leads to the formation of ergosterol as the major end product of the pathway, the 
content of which in S. cerevisiae can reach 5% of the dry weight (Lamačka and Šajbidor, 1997). 
Yeast therefore has a high inherent capacity for the biosynthesis of isoprenoid precursors that 
may be directed to the production of heterologous compounds.  
In this study, we chose S. cerevisiae as a host cell for heterologous production of three different 
plant sesquiterpenes namely valencene, cubebol and patchoulol. These three compounds are 
derived directly in a single enzymatic step from farnesyl diphosphate (FPP), the biological 
precursor for all sesquiterpenes. In the case of ergosterol, FPP is converted to squalene by 
squalene synthase, which is encoded by the ERG9 gene. In order to increase the level of FPP and 
direct flux towards sesquiterpenes an obvious strategy is to attenuate the expression of the ERG9 
gene. Since ergosterol is vital for yeast growth and yeast cells are unable to assimilate 
exogeneous ergosterol during aerobic growth conditions, this gene can not be completely deleted. 
We therefore controlled the ERG9 expression by using the MET3 promoter (Gardner and 
Hampton, 1999; Mountain et al., 1991) to drive the expression of ERG9. This strategy has been 
successfully reported to increase two-fold the final titer of amorphadiene in an engineered yeast 
strain (Ro et al., 2006). 
 Since sesquiterpenes are highly volatile compounds loss of produced sesquiterpenes during 
fermentation through the off-gas is a major problem for characterization of the engineered strains 
(Martin et al., 2001; Martin et al., 2003). To circumvent this problem in-situ separation of 
released sesquiterpenes was performed in a two-phase fermentation using an organic solvent as 
the secondary phase.  
 
MATERIALS AND METHODS 
Cloning of MET3 Promoter 
The MET3 promoter was amplified from genomic DNA of S. cerevisiae CEN.PK 113-7D using 
the primers ggactagtcctTGGTATAAGGTGAGGGGGTCCACAG and 
tccccgcggggaGAATACCACCGTGAGGAGCAGGCATG. The PCR conditions were in 
accordance with the Expand High Fidelity standard conditions (Roche Applied Science). 
Subsequently, the PCR fragments were digested by the restriction enzymes SpeI and SacII. In 
parallel, pUG6 plasmid (Güldener et al., 1996) was digested by the same couple of restriction 
enzymes. The DNA fragments were separated by gel electrophoresis and gel purified using the 
QIAEX® II Gel extraction kit (Qiagen). 
In vitro ligation of the digested plasmid with the digested PCR products was performed as the 
standard procedure given for T4 DNA ligase (Roche Applied Science). The resulting ligation mix 
was used to transform chemically competent E. coli cells (DH5α) (Inoue et al., 1990). 
Transformants were selected on LB medium supplemented with ampicillin (50 mg/L). The 
plasmid obtained was named pIP007. 
 ERG9 Promoter Replacement by MET3 Promoter 
In order to replace the ERG9 promoter by the MET3 promoter, fusion PCR and a bipartite gene 
targeting method (Erdeniz et al., 1997) were applied. Four fragments were separately amplified 
before fusing them together in pairs. First, two fragments containing the MET3 promoter and the 
KanMX selection cassette were amplified from pIP007 in two separate, but overlapping, 
fragments using the 2 couples of primers:  
gatccccgggaattgccatgACGCTGCAGGTCGACAACCC/CCATGAGTGACGACTGAATCCGG 
(Fragment A) and 
CTATCGATTGTATGGGAAGCCCG/caatgccaattgtaatagcttcccatGTTAATTATACTTTATTCT
TGTTATTATTATAC (Fragment B). Furthermore, 500 bp upstream of the ERG9 promoter in the 
genome of S. cerevisiae were amplified using primers AGCCTCAGTACGCTGGTACCCG and 
catggcaattcccggggatcTGGGCTATGAAATGTACTGAGTCAG (Fragment C). The first 500 bp 
of the ERG9 ORF were as well amplified using primers 
ATGGGAAAGCTATTACAATTGGCATTG and GTCGTAGTCGTGGACGGTTTGC 
(Fragment D). 
The resulting 4 PCR fragments were gel purified using the High Pure PCR Product Purification 
kit (Roche Applied Science) and subsequently fused together in pairs using fusion PCR. Fused 
fragments A and C were obtained after a fusion PCR using primers 
AGCCTCAGTACGCTGGTACCCG and CCATGAGTGACGACTGAATCCGG while fused 
fragments B and D were obtained after a fusion PCR using primers 
CTATCGATTGTATGGGAAGCCCG  and GTCGTAGTCGTGGACGGTTTGC. The two final 
fusion PCR fragments were gel purified with the High Pure PCR Product Purification kit (Roche 
Applied Science). 
 Strain Construction 
Strain S. cerevisiae YIP-0V-01, obtained by transformation of strain YIP-00-03 by the plasmid 
pIP031 (plasmid obtained by cloning GFTpsD in pYX212 using EcoRI and NheI sites) was 
transformed with the obtained fusion PCR fragments to result in strain YIP-MV-02. 
Strain YIP-M0-04 was obtained after exclusion of plasmid pIP031 from strain YIP-MV-02 by 
selection on plates containing 5-fluoroorotic acid (5-FOA). Strains YIP-MC-02, YIP-MV-01 and 
YIP-MP-01 were obtained after transformation of strain YIP-M0-04 by either pIP032 (obtained 
by cloning GFTpsC into pYX212 using EcoRI and NheI sites), pIP027 (obtained by cloning 
GFTpsD into pESC-URA using AgeI and SacII sites) or pIP029 (obtained by cloning PatTps177 
into pESC-URA using BamHI and XhoI sites), respectively. 
Transformation of strain YIP-00-03 by either pIP032, pIP013 (obtained by cloning of GFTpsC 
into pESC-TRP by Gap repair using the 2 primers 
ATACTTTAACGTCAAGGAGAAAAAACCCCGGATCCCGTTatggcacttcaagattcaga and 
TCTTCTTCGGAAATCAACTTCTGTTCCATGTCGACGCTtcaaaagggaacaggcttct), pIP027 or 
pIP029 led to strains YIP-0C-01, YIP-0C-02, YIP-0V-02 and YIP-0P-02, respectively. Table 1 
demonstrates the strains used in this study. 
Sequences of the genes GFTpsD (valencene synthase), GFTpsC (cubebol synthase) and 
PatTps177 (patchoulol synthase) can be obtained from Genbank: accession numbers CQ813508, 
CQ813505 and AY508730, respectively. 
 
Media for Shake Flasks 
Baffled, cotton-stopped, 500 ml Erlenmeyer flasks were used for preparing pre-cultures and also 
for investigating the effect of different organic solvents on growth. The shake flasks contained 
 100 ml medium with the following composition: 7.5 g/L (NH4)2SO4; 14.4 g/L KH2PO4; 0.5 g/L 
MgSO4.7H2O; 2 ml/L trace metal solution; 1 ml/L vitamin solution and 50 µl/L synperonic 
antifoam (Sigma). The pH of mineral medium was adjusted to 6.50 by adding 2M NaOH and 
autoclaved separately from the carbon source solution. Vitamin solution was filter sterilized and 
aseptically added to the medium after autoclaving. Shake flasks were incubated in a shaking 
incubator at 30 ºC and 150 rpm. 
 
Media for Batch Cultivations 
A defined minimal medium as described by Verduyn et al. (1992) containing 20 g/L of either 
glucose or galactose as the sole carbon source was used for all batch fermentations. The media 
had the following compositions: 5 g/L (NH4)2SO4; 3 g/L KH2PO4; 0.5 g/L MgSO4.7H2O; 1 ml/L 
trace metal solution; 1 ml/L vitamin solution and 50 µl/L synperonic antifoam.  
Glucose and galactose were autoclaved separately from the medium and subsequently added to 
the fermenter, as was the case for the vitamin solution that was added after filter sterilization.  
Expression of ERG9 was repressed by supplementing media with 2 mM filter sterilized 
methionine.  
 
Batch Fermentations 
Batch fermentations were carried out in well-controlled 5 L in-house manufactured glass 
bioreactors with a working volume of 4 L. The bioreactors were equipped with two disk-turbine 
impellers and 4 baffles to ensure proper mixing. The pH was controlled between 4.95 and 5.05 by 
automatic addition of 2M NaOH. The temperature was kept constant at 30 ºC.  The air flow was 
4 L/min (1 vvm) and was sterilized by filteration and the off gas passed through a condenser. 
 Agitation was adjusted to maintain the dissolved oxygen tension above 20% of air saturation. 
Carbon dioxide and oxygen concentrations in the off-gas were determined by a Brüel & Kjær 
acoustic gas analyzer (Brüel & Kjær, Denmark). Batch fermentors were inoculated to an initial 
OD600 of 0.02 from a liquid pre-culture. 300 ml dodecane was added aseptically to the media at 
OD600 0f 1 ± 0.1. 
 
OD and Dry Weight Determinations 
The OD of samples was determined at 600 nm in duplicate by using a Hitachi U-1100 
spectrophotometer. Dry weight measurement was achieved by using 0.45 µm pore-size 
nitrocellulose filters (Sartorius AG, Göttingen, Germany) according to the method described by 
Dynesen et al. (1998).  
 
Determination of Ergosterol Content 
Ergosterol content of yeast cells was determined as described by Breivik and Owades (1957) with 
slight modifications. 500 ml baffled, cotton-stopped, shake flasks containing 100 ml minimal 
medium and 20 g/L glucose as carbon source were inoculated with one colony of different yeast 
strains and incubated for 24 h in a shaking incubator at 30 ºC and 150 rpm. A certain volume of 
culture media corresponding to approximately 100 mg of dry cells was harvested by centrifuging 
at 3000 rpm for 5 min. The cell pellet was washed with distilled water and the cell suspension 
was centrifuged for another 5 min at 3000 rpm. 10 ml of 25% alcoholic potassium hydroxide 
solution (dissolving 25 g KOH in distilled water to 40 ml and then brought to 100 ml with 
absolute ethanol) was added to each pellet and vortex mixed for 1 min. Cell suspensions were 
transferred to 100 ml round bottom flasks. The flasks were connected to a water cooled 
 condenser and samples were saponified in a water bath for 3 h at 90 ºC.  Following incubation 
flasks were allowed to cool to room temperature. The contents of flasks were transferred to new 
glass tubes and the non-saponified sterols were extracted by adding 10 ml heptane followed by 
vigorous vortex mixing for 2 min. For each set of experiments a fresh blank was prepared by 
adding 10 ml heptane to 10 ml of alcoholic potassium solution and vortex mixing for 2 min. After 
30 min when the heptane layer had clarified, 0.5 ml of heptane layer in both sample and blank 
was diluted ten-folds in 4.5 ml absolute ethanol. The absorbance of all samples was read against 
blank at 230 and 281.5 nm. The ergosterol content was calculated as milligram ergosterol per 
gram dry weight using the following equation:  
FODODgDWmgErgosterol nm ×⎟⎠
⎞⎜⎝
⎛ −=
518290
)/( 2305.281  
where F is a correction factor for dilutions and sample sizes and 290 and 518 are E(1%, 1 cm) of 
crystalline ergosterol and 24(28)-dehydroergosterol, respectively.  
 
Analysis of Sugars and Extracellular Metabolites 
To determine the concentration of sugars and extracellular metabolites in the culture media, 2 ml 
samples were withdrawn from the fermentor and immediately filtered through a 0.45 µm pore-
size cellulose acetate filter (Sartorius AG, Göttingen, Germany).  The filtrate was stored at -20 ºC 
until HPLC analysis. Glucose, galactose, glycerol, pyruvate, succinate, acetate, and ethanol 
concentrations were determined in a Waters 717 plus Autosampler HPLC system equipped with a 
Bio-Rad Aminex HPX-87H reverse phase column (Biorad, Hercules, CA) at 60 ºC using 5 mM 
H2SO4 as mobile phase at a flow rate of 0.6 ml/min. Glucose, galactose, glycerol, succinate, and 
ethanol were detected refractometrically (Waters 410 Differential Refractometer Detector, 
 Millipore Corp., Milford, MA). Pyruvate and acetate were determined spectrophotometrically 
with a Waters 490E Programmable Multiwavelength Detector set at 210 nm 
 
Analysis of Sesquiterpenes in the Organic Layer  
Samples from organic layer were centrifuged for 5 min at 3500 rpm and subsequently analyzed 
by GC-MS to determine the level of sesquiterpenes during the course of fermentation. GC-MS 
analyses were run on a Thermo Finnigan Focus GC coupled to a Focus DSQ quadrupole mass 
spectrometer. Analytes from 1 µl samples were separated on a SLB-5ms capillary column (30 m 
× 0.25 mm i.d., 0.25 µm film thickness; Supelco, Bellefonte, PA, USA) using helium as carrier 
gas at the flow rate of 1.2 ml/min. A split/splitless injector was used in the splitless mode. The 
initial oven temperature was 80 ºC and injector temperature was 250 ºC. After 1 min the oven 
temperature was increased to 120 ºC at the rate of 10 ºC/min and subsequently increased to 160 
ºC at the rate of 3 ºC/min. The oven temperature was finally increased to 270 ºC at the rate of 10 
ºC/min and held for 5 min at this temperature.  
Quantification of compounds was carried out using standard curves generated after each analysis 
run.    
 
Identification of Sesquiterpenes by Solid Phase Microextraction (SPME) Method 
Identification of sesquiterpenes in the yeast strains transformed with heterologous sesquiterpene 
synthases was performed by extracting volatile compounds from the head-space of the samples 
on 100 µm polydimethyl siloxane (PDMS) fibers (Supelco, Bellefonte, PA, USA). Fibers were 
conditioned according to the suppliers’ instruction. Two ml samples from the culture media were 
immediately frozen and stored in 4 ml screw cap glass vials at -20 ºC until analysis. The contents 
 of vials were thawed on ice and allowed to equilibrate at room temperature. Extraction was 
performed for 25 min at 60 ºC while mixing the sample with a small magnet. After extraction the 
analytes were thermally desorbed at 250 ºC from SPME fiber into the injector of gas 
chromatogram in the splitless mode. The oven temperature was held initially at 45 ºC for 1 min, 
then raised to 130 ºC by a ramp of 10 ºC/min followed by a ramp of 3 ºC/min to 160 ºC. The 
oven temperature was further raised to 250 ºC at 10 ºC/min and maintained at this temperature for 
5 min to equilibrate.  
 
Analysis of Methionine 
The concentration of methionine in the media was measured by HPLC by the method of Barkholt 
and Jensen (1989).  
 
RESULTS 
Sesquiterpene Synthase Genes are Functional in the Engineered Yeast Strains 
Yeast strains were transformed with individual plasmids bearing one of the three sesquiterpene 
synthase cDNAs under control of TPI or GAL promoters: a valencene synthase (GFTpsD) and a 
cubebol synthase (GFTpsC) from grapefruit and a patchoulol synthase (PatTps177) from 
patchouli. To confirm the functionality of these plasmids the transformed strains were grown in 
shake flasks containing 100 ml minimal medium and 20 g/L galactose as carbon source. Volatile 
compounds were adsorbed on SPME fibers and analyzed by GC-MS. All the transformed strains 
were able to synthesize sesquiterpenes. In the case of valencene synthase, valencene was clearly 
the major product (Fig. 1-a) in accordance with the relative high product specificity observed 
with this enzyme in in-vitro assay (data not shown). However, the patchoulol synthase and the 
 cubebol synthase are multiple product enzymes. The patchoulol synthase produces, in in-vitro 
assays, 14 different sesquiterpenes with patchoulol as major product (Deguerry et al, 2006). 
Similarly, the cubebol synthase produces mainly cubebol besides at least 14 additional products 
(unpublished data). Analysis of the volatiles produced by yeast cells transformed with either the 
patchoulol or cubebol synthase cDNA revealed the similar sesquiterpene profiles as observed in 
the in-vitro assays. Figures 1-b and 1-c illustrate the range of sesquiterpene products produced by 
the cubebol synthase from grapefruit and patchoulol synthase from patchouli, respectively.  
 
Minimum Methionine Concentration for ERG9 repression 
The minimum concentration of methionine for adjusting the expression of ERG9 was determined 
by growing the ERG9 repressed yeast cells in shake flasks supplemented with varying amounts of 
methionine (Fig. 2).  
Repression of ERG9 led to lower specific growth rates compared to the wild type strain and also 
reduced the final concentration of biomass in the medium presumably as a result of decreased 
flux towards ergosterol. Increasing the methionine concentration to 1 mM resulted in an 
elongation of the lag phase and a lower final biomass concentration. However, there was no 
further effect on growth profile at concentrations of methionine above 1 mM (Fig. 2). So the 
minimum required level of methionine should be 1 mM. However, to maintain the concentration 
of methionine at the minimum required level for ERG9 repression during the course of 
fermentation, 2 mM methionine was chosen for running fermentations.  
Repression of ERG9 is likely to decrease the ergosterol content in the yeast strains. This was 
confirmed by determining the ergosterol content of the ERG9 repressed strains and comparing to 
wild type. For the wild type the ergosterol content was found to be 18.75 ± 1.92 mg ergosterol/g 
 DW, whereas it was found to be 14.95 ± 2.91 mg ergosterol/g DW for YIP-MV-02 when there 
was no methionine added to the medium and 3.31 ± 0.04 mg ergosterol/g DW when 2 mM 
methionine was added to the medium.   
 
Screening Different Solvents for in situ Separation of Sesquiterpenes 
The volatility and low solubility of sesquiterpenes proved a major practical problem in 
characterizing the engineered sesquiterpene producing strains (data not shown). To circumvent 
this problem a two-phase fermentation using a biocompatible organic solvent was developed for 
the characterization of the constructed strains. Two-phase fermentation has been reported for in 
situ separation of amorphadiene produced by metabolically engineered E. coli (Newman et al, 
2006).  
Selection of an appropriate solvent is the key driver for successful operation of a two-phase 
fermentation. We first identified three different organic solvents (diisononyl phthalate, oleyl 
alcohol, and dodecane) which seemed to have suitable characteristics (biocompatibility, 
immiscibility, and low volatility) and investigated their applicability in two-phase fermentations 
in shake flasks with S. cerevisiae. None of these solvents had significantly detrimental effects on 
the specific growth rate (Fig. 3). However, phase separation was faster and clearer when 
dodecane was the organic solvent, and this solvent was therefore chosen for the subsequent 
experiments. The effect of dodecane on the growth was further examined in a 5 L batch 
fermenter, and it was found not to have any negative effects on cell growth (data not shown). 
 
 
 Two-Phase Fermentation: An Efficient Technique for Characterizing the Engineered 
Sesquiterpene Producing Yeast Strains 
Yeast strains transformed with plasmids harboring each of the three sesquiterpene synthase genes 
under control of either TPI or GAL promoters were characterized in two-phase 5 L batch 
fermenters containing 4 L minimal medium and 20 g/L galactose. Samples were taken from the 
organic phase at different times and were analyzed for sesquiterpene content. Time-course 
analysis (Fig. 4) showed collectively accumulation of sesquiterpenes in the dodecane phase as 
cells were growing and proved the potential of this system for capturing the volatile, hydrophobic 
compounds. At the end of each fermentation a sample from the aqueous phase was analyzed by 
SPME to check the presence of sesquiterpenes in the aqueous phase. However no sesquiterpenes 
were detectable reflecting the high partition coefficient of these compounds into the dodecane 
phase. 
Table 2 summarizes the final concentrations and yields of the sesquiterpenes for the yeast strains 
harboring synthase genes. However patchoulol constitutes only 37% of the total sesquiterpenes 
synthesized by the patchoulol synthase (Deguerry et al., 2006) and the total concentration and 
yields of this sesquiterpene (strain YIP-0P-02) are significantly higher than for the other strains 
indicating higher activity of patchoulol synthase than valencene and cubebol synthases. In the 
same way, cubebol represents only 28% of sesquiterpenes produced by the cubebol synthase 
(unpublished data) and the total quantities of sesquiterpenes produced by strains expressing this 
enzyme are higher than for strains expressing the valencene synthase  indicating that cubebol 
synthase is also more active than valencene synthase. Total sesquiterpene concentrations were 
estimated based on the known percentage of the target sesquiterpenes produced by the different 
sesquiterpene synthases (28% and 37% for cubebol and patchoulol, respectively).  
 Replacement of GAL promoter with TPI promoter for controlling cubebol synthase gene reduced 
the efficiency of sesquiterpene production both in term of final concentration and yield when 
galactose was the carbon source (YIP-0C-01 vs. YIP-0C-02). 
 
ERG9 Repression Diverts FPP towards Farnesol  
Analysis of dodecane layer from two-phase batch fermentation of the ERG9 repressed strain 
without any sesquiterpene synthase (YIP-M0-04) revealed formation of farnesol as an FPP-
derived compound during fermentation .  
The yield of farnesol when cells were assimilating galactose as carbon source was 10.90 mg/g 
DW and the final titer was 22.6 mg/L. The concentration and yield of the compounds directly 
derived from FPP are higher when ERG9 is repressed. Taken together with the reduced ergosterol 
content of the ERG9 repressed strains, this confirms the possibility of using this strategy for 
enhancing FPP availability for the sesquiterpene synthases.  
 
Combination of ERG9 Repression and Sesquiterpene Synthase Expression 
ERG9 repression was shown to result in formation of FPP derived by-products and therefore it is 
likely that FPP availability for sesquiterpene synthases was improved. Hence, combination of 
ERG9 repression and sesquiterpene synthase expression was expected to give rise to higher 
accumulation of sesquiterpenes. To investigate this hypothesis the YIP-M0-04 strain was 
transformed with plasmids each bearing one of the three sesqueterpene synthase genes and the 
constructed strains were characterized in 5 L batch fermenters. None of the sesquiterpene 
synthase genes were able to convert all the available FPP to the target sesquiterpene and again 
farnesol was observed as FPP derived by-product (Fig. 5).  
 Comparing the final concentrations of desired sesquiterpenes and farnesol produced by ERG9 
repressed strains and the corresponding strains where ERG9 is under control of the endogenous 
promoter (Table 2 and Table 3) indicate that except for the patchoulol synthase, repression of 
ERG9 did not lead to significantly higher amounts of sesquiterpenes but mainly resulted in the 
diverting of FPP to farnesol. This again shows that patchoulol synthase activity in the yeast cells 
is higher than the activities of the other two sesquiterpene synthases. 
Replacing the GAL promoter in the YIP-MV-01 strain with TPI promoter (YIP-MV-02) resulted 
in lower amount of valencene and higher yield and concentration of farnesol.  
 
Regulating Methionine Concentration Alters the Flux towards Sesquiterpenes  
ERG9 downregulation was not concomitant with considerable improvement in the final 
concentrations of the target sesquiterpenes, but comparing the yields (Table 2 and Table 3) 
demonstrates that there was some increase in the yields. Plotting the sesquiterpene concentration 
versus dry weight of biomass or galactose concentration allowed calculation of yields and this 
revealed two different linear phases during  the galactose consumption phase (Fig. 6) suggesting 
that the rate of sesquiterpene accumulation in the organic phase dropped at one time during the 
fermentation. It was speculated that methionine was metabolized by the cells and the subsequent 
reduced levels of methionine would relieve a true repression of the ERG9 gene and consequently 
lowered the accumulation rate of sesquiterpenes. Analyzing the methionine concentration in the 
culture media confirmed that there was a total consumption of methionine (data not shown). To 
examine the effect of methionine concentration on the level of products we therefore ran 
fermentations with the YIP-MP-01 strain using higher amounts of methionine added to the 
medium at different times during fermentation. Maintaining the methionine concentration at 
 higher level during the fermentation resulted in a 47% increase in the final patchoulol titer and a 
82% increase in the final farnesol titer. Thus, the final concentrations of patchoulol and farnesol 
reached to 16.9 and 20.2 mg/L, respectively. 
 
Farnesol is Converted to other By-Products at the End of Fermentation 
It was noticed that there is a drastic drop in the farnesol concentration for the ERG9 repressed 
strains when all carbon sources had been depleted. This decrease could not be a result of 
evaporation of farnesol from the organic phase since the same pattern was not observed for other 
compounds. We speculated that at the end of fermentation and after depletion of all carbon 
sources, farnesol is further converted to other related compounds and appearance of a second 
peak during GC-MS analysis for FPP-derived compounds at the end of the fermentations 
supported this hypothesis (Fig. 7).  
 
Galactose is Preferred Carbon Source for Biosynthesis of Sesquiterpenes  
Galactose is an expensive carbon source and S. cerevisiae posses a lower specific growth rate on 
this carbon source. Therefore for industrial fermentation it would be desirable to use glucose as 
carbon source. We investigated the possibility of using glucose in the media by growing yeast 
cells expressing cubebeol and valencene synthases under control of the TPI promoter (YIP-MC-
02 and YIP-MV-02, respectively) using glucose rather than galactose as carbon source. However, 
the results showed that both the final titer and the yield were lower when cells were grown on 
glucose (Table 3 and Table  4).  
 
 
 DISCUSSION 
In this study we report heterologous production of three different plant sesquiterpenes in the yeast 
S. cerevisiae. The corresponding sesquiterpene genes for cubebol, valencene and patchoulol were 
expressed in yeast and were shown to be functional, and this is the first instance of a cubebol 
synthase being expressed for heterologous production of cubebol.  
Volatility of the sesquiterpenes and the loss of a considerable amount of products through the off-
gas was a bottleneck for characterization of the constructed strains. To overcome this problem, 
we demonstrated the in situ separation of the synthesized sesquiterpenes using a two-phase 
fermentation process, where the second phase was an organic solvent. We examined three 
organic solvents (dodecane, diisononyl phthalate and oleyl alcohol), and none of these solvents 
showed significantly detrimental effect on the growth rate. For further work we chose dodecane 
since phase separation was faster and more distinct for this solvent.  
The availability of FPP which is the precursor for all sesquiterpene synthases was enhanced by 
replacement of the native ERG9 promoter with a regulatable MET3 promoter and repressing the 
promoter with the presence of 2 mM methionine. The ergosterol content was drastically reduced 
as a consequence of this repression. Nevertheless, this strategy did not improve appreciably the 
production of the target sesquiterpenes but resulted in further production of farnesol as an FPP-
derived by-product. Consistent with this finding are accumulation of farnesol in Candida 
albicans (Buurman et al., 2004; Hornby et al., 2003) as a consequence of treatment with 
zaragozic acid, which is potent inhibitor of squalene synthase. Furthermore, deletion of ERG9 
gene in S. cerevisiae was reported to lead to accumulation of farnesol in S. cerevisiae (Song, 
2003). Poor expression of the plant sesquiterpene genes may explain why sesquiterpene synthesis 
was not improved significantly after repression of ERG9. The use of codon optimized 
 sesquiterpene synthases may help in diverting more FPP towards the desired sesquiterpenes. The 
production of amorphadiene in yeast was significantly enhanced when the codon usage of the 
amorphadiene synthase was optimized (Martin et al., 2001; Martin et al., 2003). 
Metabolism of methionine during the growth phase relieved the repression of ERG9, which was 
accompanied by a reduction in the rate of sesquiterpene synthesis. Further experiments showed 
that it was possible to improve the sesquiterpene production by supplying more methionine 
during fermentation. Under these conditions the final titer of patchoulol and farnesol reached to 
16.9 and 20.2 mg/L, respectively. More precise regulation of methionine should improve further 
the efficiency of sesquiterpene generation.  
The effect of replacing galactose as an expensive carbon source with glucose, which is less 
expensive and is faster metabolized by cells, on the sesquiterpene biosynthesis was investigated.  
However, higher final titer and yield were observed when cells were grown on galactose.  
Considering that the reported titers and yields have been achieved only by downregulating one 
gene in the pathway, this work demonstrates the capacity of yeast as a cell factory for the 
production of sesquiterpenes. 
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 Figure Legends 
Figure 1. GC profile of the sesquiterpenes produced by yeast strains expressing (a) valencene 
synthase (YIP-0V-02) (b) cubebol synthase (YIP-0C-02) (c) patchoulol synthase (YIP-0P-02) 
 
Figure 2. Effect of methionine on growth pattern of ERG9 repressed yeast strain (YIP-MV-02) 
cultivated in shake flasks containing minimal medium and 20 g/L glucose. (Without methionine: 
□; 0.25 mM methionine: ■; 0.50 mM methionine: ▲; 1.0 mM methionine: U; 1.5 mM 
methionine: ; 2 mM methionine: ) 
 
Figure 3. Growth pattern of YIP-0V-01 strain in the presence of 10% (v/v) different organic 
solvents; No solvent: ●; Diisononyl phthalate: T; Dodecane: ○; Oleyl alcohol: U  
Cells were cultivated in shake flasks containing 100 ml minimal medium and 15 g/L glucose. 
Organic solvent was added aseptically at OD=1 ± 0.1. 
 
Figure 4. Sesquiterpene concentration as a function of time for yeast strains expressing 
sesquiterpene synthases (a) YIP-0C-01 (b) YIP-0C-02 (c) YIP-0V-02 (d) YIP-0P-02 
 
Figure 5. Target sesquiterpenes and farnesol concentrations as a function of time for ERG9 
repressed yeast strains expressing sesquiterpene synthases (a) YIP-MC-02 (b) YIP-MV-01 (c) 
YIP-MV-02 (d) YIP-MP-01; Valencene (♦) Cubebol (●) Patchoulol (■) Farnesol (U) 
 
 Figure 6. Target sesquiterpenes and farnesol concentrations as a function of galactose 
concentration for calculating yields on galactose. (a) YIP-MV-01 (b) YIP-MC-02 (c) YIP-MP-
01; Valencene (♦) Cubebol (●)  Patchoulol (■) Farnesol (U) 
 
Figure 7. Farnesol degradation at the end of fermentation and appearance of an unknown 
compound. (a) YIP-MV-01 (b) YIP-MC-02; Farnesol (U) Unknown comound (●) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Table Legends 
Table 1. Strains used in this study 
 
Table 2. Final concentrations of target sesquiterpenes and total sesquiterpenes and yields of target 
sesquiterpenes (mg sesquiterpene per gram dry weight or gram consumed galactose in the 
galactose consumption phase) for yeast strains expressing sesquiterpene synthases. Cells were 
grown in 5 L batch fermenters containing 4 L minimal medium and 20 g/L galactose. 
 
Table 3. Final concentrations and yields of sesquiterpenes for the ERG9 repressed yeast strains. 
Cells were grown in 5 L batch fermenters containing 4 L minimal medium and 20 g/L galactose. 
 
Table 4. Final concentrations and yields of sesquiterpenes and farnesol for the ERG9 repressed 
yeast strains expressing sesquiterpene synthases under control of TPI promoter. Cells were grown 
in 5 L batch fermenters containing 4 L minimal medium and 20 g/L glucose. 
 
 
 
 
 
 
 
 
 
Table 1.  
Strain Genotype Plasmid Plasmid description 
YIP-00-03 
(CEN.PK113-5D) 
MATa MAL2-8c SUC2 ura3-52 none  
YIP-0C-01 MATa MAL2-8c SUC2 ura3-52 pIP032 pYX212 2µ URA3 PTPI1-GFTpSC 
YIP-0C-02 MATa MAL2-8c SUC2 trp1-289 pIP013 pESC-TRP 2µ TRP1 PGAL1-GFTpSC 
YIP-0P-02 MATa MAL2-8c SUC2 ura3-52, pIP029 pESC-URA 2µ URA3 PGAL1- PatTps177
YIP-0V-01 MATa MAL2-8c SUC2 ura3-52 pIP031 pYX212 2µ URA3 PTPI1-GFTpSD 
YIP-0V-02 MATa MAL2-8c SUC2 ura3-52 pIP027 pESC-URA 2µ URA3 PGAL1- GFTpSD 
YIP-M0-04 
MATa MAL2-8c SUC2 ura3-52, 
erg9 ::PMET3-ERG9 
none  
YIP-MC-02 
MATa MAL2-8c SUC2 ura3-52, 
erg9 ::PMET3-ERG9 
pIP032 pYX212 2µ URA3 PTPI1-GFTpSC 
YIP-MP-01  
MATa MAL2-8c SUC2 ura3-52, 
erg9 ::PMET3-ERG9 
pIP029 pESC-URA 2µ URA3 PGAL1- PatTps177
YIP-MV-01 
MATa MAL2-8c SUC2 ura3-52, 
erg9 ::PMET3-ERG9 
pIP027 pESC-URA 2µ URA3 PGAL1- GFTpSD 
YIP-MV-02 
MATa MAL2-8c SUC2 ura3-52, 
erg9 ::PMET3-ERG9 
pIP031 pYX212 2µ URA3 PTPI1-GFTpSD 
 
 
Table 2.  
Yeast strain Promoter 
Valencene 
(mg/L) 
Cubebol 
(mg/L) 
Patchoulol 
(mg/L) 
Total 
sesquiterpenes 
(mg/L) 
YXP 
(mg/g 
DW) 
YSP 
(mg/g 
galactose) 
YIP-0V-02 GAL1 2.0   2.0 0.33 0.08 
YIP-0C-02 GAL1  2.0  7.1 0.33 0.07 
YIP-0C-01 TPI1  1.5  5.4 0.21 0.04 
YIP-0P-02 GAL1   6.7 18.1 1.21 0.31 
 
Table 3.  
Yeast strain 
Sesquiterpene 
synthase 
Promoter 
Final titer of 
target 
sesquiterpene 
(mg/L) 
Total 
sesquiterpenes 
(excluding 
farnesol) 
(mg/L) 
Farnesol 
(mg/L) 
Yield of 
target 
sesquiterpene 
on biomass 
(mg/g DW) 
Yield of target 
sesquiterpene 
on galactose 
(mg/g 
galactose) 
Yield of 
farnesol on 
biomass 
(mg/g DW) 
Yield of 
farnesol 
on 
galactose 
(mg/g 
galactose) 
YIP-MC-02 Cubebol TPI1 1.6 5.7 29.9 0.39 0.23 13.15 5.30 
YIP-MV-01 Valencene GAL1 3.0 3.0 19.6 3.13 0.67 9.05 3.77 
YIP-MV-02 Valencene TPI1 0.6 0.6 34.6 0.38 0.14 14.93 5.99 
YIP-MP-01 Patchoulol GAL1 11.5 31.1 11.1 6.25 2.13 4.98 2.06 
YIP-M0-04 ---- ---- ---- 0 22.6 0 0 10.90 1.76 
 
Table 4.  
Yeast strain 
Valencene 
(mg/L) 
Cubebol 
(mg/L) 
Farnesol 
(mg/L) 
Yield of 
corresponding 
sesquiterpene 
on glucose 
(mg/g 
glucose) 
Yield of 
farnesol on 
glucose (mg/g 
glucose)  
YIP-MC-02  1.5 20.0 0.05 0.82 
YIP-MV-02 0.2  15.7 0.01 0.84 
 







